News
Private equity’s GTCR is selling Vernon Hills-based Antylia Scientific, a maker of molecular diagnostic reagents, specialty ...
GTCR is already on track to return a record $5 billion-plus to investors for a calendar year, people familiar with the matter ...
Cohen said GTCR believes investors can still derive much value from broker consolidation plays in the UK and the US, but said ...
Private equity firm GTCR is set to return more than $5 billion to its investors in the calendar year, a source familiar with the matter told Reuters on Thursday, after a string of strong exits sealed ...
In an interview with sister title Insurance Insider US, Aaron Cohen, head of financial services and technology at ...
Hosted on MSN3mon
GTCR Raises $3.6 Billion for Second Strategic Growth Fund(Bloomberg) -- Private equity firm GTCR raised $3.6 billion for a second strategic growth fund, surpassing its $2.75 billion target and boosting its firepower for smaller buyouts, according to a ...
NEW YORK, April 17 (Reuters) - Private equity firm GTCR is poised to garner a return of about two times its investment in Worldpay, after the sale of its 55% stake in the payments processor to ...
Sale of Industry-Leading Payments Technology and Solutions Company Marks an Important Milestone in GTCR's Strategic Transformation in Partnership with Leaders Strategy™ CEO Charles Drucker ...
The private-equity firm GTCR has agreed to sell a big stake in Ultimus Fund Solutions that values the administrative-services provider at nearly $2 billion, according to people familiar with the ...
CHICAGO, May 20, 2025 /PRNewswire/ -- GTCR, a leading private equity firm, announced that it has signed a definitive agreement to sell ITEL Laboratories, Inc. ("itel" or "the Company"), a leading ...
CHICAGO, Oct. 9, 2024 /PRNewswire/ -- GTCR, a leading private equity firm, announced today the promotions of four senior team members, as well as the addition of two new senior hires for the firm.
In the FTC’s first merger challenge of the new administration, the FTC voted 4-0 last week to challenge the proposed acquisition of Surmodics by private equity firm GTCR BC Holdings (“GTCR”).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results